|
| Status |
Public on May 13, 2016 |
| Title |
Investigation of gene expression alterations of pancreatic cancer caused by Deferasirox administration |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
To investigate the genetic effect of Deferasirox in pancreatic cancer, we examined gene expression alternations in the removed tumors exposed to Deferasirox.
|
| |
|
| Overall design |
Pancreatic cancer cells (BxPC-3) in culture were harvested and viable cells were injected subcutaneously into the backs of the mice. When tumor volumes reached 150 mm3, treatment began. The treatment group of mice received Deferasirox suspended in saline, which was administered by oral gavage every second day, with three treatments per week, over 21 days at concentrations of 200 mg/kg. The control mice were treated with the vehicle alone. At the end of the experiment, the mice were sacrificed and the tumors were excised and processed for genetic analyses. A total of 6 tumors were analyzed. Of these, 3 tumors were removed from vehicle-treated mice, and the other 3 tumors were removed from Deferasirox 200 mg/kg-treated mice.
|
| |
|
| Contributor(s) |
Harima H |
| Citation(s) |
27582255, 32698792 |
| |
| Submission date |
May 12, 2016 |
| Last update date |
Jul 27, 2020 |
| Contact name |
Hirofumi Harima |
| E-mail(s) |
harima@yamaguchi-u.ac.jp
|
| Organization name |
Yamaguchi University Graduate School of Medicine
|
| Department |
Department of Gastroenterology and Hepatology
|
| Street address |
Minami Kogushi 1-1-1
|
| City |
Ube |
| State/province |
Yamaguchi |
| ZIP/Postal code |
755-8505 |
| Country |
Japan |
| |
|
| Platforms (1) |
| GPL17077 |
Agilent-039494 SurePrint G3 Human GE v2 8x60K Microarray 039381 (Probe Name version) |
|
| Samples (6)
|
|
| Relations |
| BioProject |
PRJNA321527 |
Less...
More...